54662-02-1

Basic information

• Product Name: Hydrazinecarboxylic acid, propyl ester
• Synonyms: Hydrazinecarboxylic acid, propyl ester
• CAS NO: 54662-02-1
• Molecular Formula: C₄H₁₀N₂O₂
• Molecular Weight: 118.13
• Mol File: 54662-02-1.mol
• Article Data: 5

Chemical Properties

• Appearance: /
• CAS DataBase Reference: Hydrazinecarboxylic acid, propyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: Hydrazinecarboxylic acid, propyl ester(54662-02-1)
• EPA Substance Registry System: Hydrazinecarboxylic acid, propyl ester(54662-02-1)

Safety Data

• Hazardous Substances Data: 54662-02-1(Hazardous Substances Data)

Upstream product

• 83395-37-3 3-(2-aminoethyl)-1-(4-fluorophenyl)-2-methyl-5-[4-(methylsulphonyl)phenyl]-1H-pyrrole 
• 623-96-1 Dipropyl carbonate 
• 109-61-5 propoxycarbonyl chloride 
• 7803-57-8 hydrazine hydrate 

Relevant articles and documents

Palladium-Catalyzed Oxidative C–H Alkoxycarbonylation of Arenes with Alkylcarbazates Directed by N-Heterocyclic Substituents

With alkyl carbazates as the green ester source, a novel palladium-catalyzed oxidative free radical carbonylative transformation of the C–H bond on aromatic rings to produce esters has been developed. Good yields of the corresponding products have been obtained with wide functional group tolerance and excellent regioselectivity. A variety of alkyl carbazates are found to be suitable reactants for the ortho-alkoxycarbonylation on the aromatic ring.

Synthesis of 6-carboxylated phenanthridines by oxidative alkoxycarbonylation-cyclization of 2-isocyanobiphenyls with carbazates

An iron-catalyzed synthesis of 6-carboxylated phenanthridines starting with readily prepared isocyanides and carbazates was developed. Reactions occurred via addition of alkoxycarbonyl radicals to the isocyanide group and subsequent intramolecular cyclization.

7-Oxabicycloheptane hydrazone prostaglandin analogs useful in treating thrombolytic diseases

7-Oxabicycloheptane hydrazone prostaglandin analogs are provided having the structural formula STR1 and including all stereoisomers thereof. pa The compounds are cardiovascular agents useful, for example, in the treatment of thrombolytic disease.